New aspects of injectable contraception

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

Despite the availability of efficacious and safe contraceptive agents, not all women's contraceptive needs are being met. An injectable contraceptive method offers convenience and encourages compliance, both very important aspects for women seeking ideal contraception. Depot medroxyprogesterone acetate (DMPA) is a long-acting injectable, and is highly effective; one injection provides 3 months of contraception. Drawbacks of DMPA include irregular bleeding and a slow return to fertility. A new monthly injectable contraceptive agent is medroxyprogesterone acetate/estradiol cypionate suspension (Lunelle). It provides menstrual regulation and a rapid return to fertility. The estrogen ensures a withdrawal bleed monthly; however, women with contraindications to estrogen-containing contraception are not candidates for Lunelle.

Original languageEnglish (US)
Pages (from-to)31-36
Number of pages6
JournalInternational Journal of Fertility and Women's Medicine
Volume46
Issue number1
StatePublished - Aug 7 2001

Fingerprint

Contraception
Medroxyprogesterone Acetate
Contraceptive Agents
Injections
Fertility
Estrogens
Compliance
Suspensions
Hemorrhage
Lunelle

All Science Journal Classification (ASJC) codes

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

New aspects of injectable contraception. / Phillips, Owen.

In: International Journal of Fertility and Women's Medicine, Vol. 46, No. 1, 07.08.2001, p. 31-36.

Research output: Contribution to journalReview article

@article{8efe4b5b22094c5aa2e1116b8b4b723c,
title = "New aspects of injectable contraception",
abstract = "Despite the availability of efficacious and safe contraceptive agents, not all women's contraceptive needs are being met. An injectable contraceptive method offers convenience and encourages compliance, both very important aspects for women seeking ideal contraception. Depot medroxyprogesterone acetate (DMPA) is a long-acting injectable, and is highly effective; one injection provides 3 months of contraception. Drawbacks of DMPA include irregular bleeding and a slow return to fertility. A new monthly injectable contraceptive agent is medroxyprogesterone acetate/estradiol cypionate suspension (Lunelle). It provides menstrual regulation and a rapid return to fertility. The estrogen ensures a withdrawal bleed monthly; however, women with contraindications to estrogen-containing contraception are not candidates for Lunelle.",
author = "Owen Phillips",
year = "2001",
month = "8",
day = "7",
language = "English (US)",
volume = "46",
pages = "31--36",
journal = "International Journal of Fertility and Women's Medicine",
issn = "1534-892X",
publisher = "Medical Science Publishing International Inc.",
number = "1",

}

TY - JOUR

T1 - New aspects of injectable contraception

AU - Phillips, Owen

PY - 2001/8/7

Y1 - 2001/8/7

N2 - Despite the availability of efficacious and safe contraceptive agents, not all women's contraceptive needs are being met. An injectable contraceptive method offers convenience and encourages compliance, both very important aspects for women seeking ideal contraception. Depot medroxyprogesterone acetate (DMPA) is a long-acting injectable, and is highly effective; one injection provides 3 months of contraception. Drawbacks of DMPA include irregular bleeding and a slow return to fertility. A new monthly injectable contraceptive agent is medroxyprogesterone acetate/estradiol cypionate suspension (Lunelle). It provides menstrual regulation and a rapid return to fertility. The estrogen ensures a withdrawal bleed monthly; however, women with contraindications to estrogen-containing contraception are not candidates for Lunelle.

AB - Despite the availability of efficacious and safe contraceptive agents, not all women's contraceptive needs are being met. An injectable contraceptive method offers convenience and encourages compliance, both very important aspects for women seeking ideal contraception. Depot medroxyprogesterone acetate (DMPA) is a long-acting injectable, and is highly effective; one injection provides 3 months of contraception. Drawbacks of DMPA include irregular bleeding and a slow return to fertility. A new monthly injectable contraceptive agent is medroxyprogesterone acetate/estradiol cypionate suspension (Lunelle). It provides menstrual regulation and a rapid return to fertility. The estrogen ensures a withdrawal bleed monthly; however, women with contraindications to estrogen-containing contraception are not candidates for Lunelle.

UR - http://www.scopus.com/inward/record.url?scp=0034918805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034918805&partnerID=8YFLogxK

M3 - Review article

VL - 46

SP - 31

EP - 36

JO - International Journal of Fertility and Women's Medicine

JF - International Journal of Fertility and Women's Medicine

SN - 1534-892X

IS - 1

ER -